How does MPRS's PB Ratio compare to its peers?

Insufficient data to calculate MPRS's Price-To-Book Ratio vs. peers for valuation analysis.

How does MPRS's PB Ratio compare vs other companies in the IL Capital Markets Industry?

Insufficient data to calculate MPRS's Price-To-Book Ratio vs. industry for valuation analysis.

What is MPRS's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate MPRS's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of MPRS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate MPRS's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

MPRS Stock Overview

A research and development life science partnership and venture capital firm specializing in seed/startups investments. More details

MPRS fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (₪12M)

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

MediPress Health-Limited Partnership Competitors

Unicorn Technologies - Limited Partnership

TASE:UNCT

₪12.8m

Big Tech 50 R&D-Limited Partnership

TASE:BIGT

₪13.9m

Almeda Ventures Limited Partnership

TASE:AMDA

₪20.5m

TechnoPlus Ventures

TASE:TNPV

₪27.7m

Price History & Performance

Summary of share price highs, lows and changes for MediPress Health-Limited Partnership
Historical stock prices
Current Share Price	₪0.81
52 Week High	₪1.15
52 Week Low	₪0.66
Beta	0
1 Month Change	13.37%
3 Month Change	n/a
1 Year Change	-15.21%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-58.08%

Recent updates

Shareholder Returns

	MPRS	IL Capital Markets	IL Market
7D	0%	2.7%	0.5%
1Y	-15.2%	63.6%	23.7%

Return vs Industry: MPRS underperformed the IL Capital Markets industry which returned 63.6% over the past year.

Return vs Market: MPRS underperformed the IL Market which returned 23.7% over the past year.

Price Volatility

Is MPRS's price volatile compared to industry and market?
MPRS volatility
MPRS Average Weekly Movement	n/a
Capital Markets Industry Average Movement	4.0%
Market Average Movement	4.2%
10% most volatile stocks in IL Market	8.0%
10% least volatile stocks in IL Market	3.0%

Stable Share Price: MPRS's share price has been volatile over the past 3 months compared to the IL market.

Volatility Over Time: Insufficient data to determine MPRS's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2021	n/a	Joseph Press	n/a

MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders.

MediPress Health-Limited Partnership Fundamentals Summary

How do MediPress Health-Limited Partnership's earnings and revenue compare to its market cap?
MPRS fundamental statistics
Market cap	₪12.22m
Earnings (TTM)	₪0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is MPRS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MPRS income statement (TTM)
Revenue	₪0
Cost of Revenue	₪0
Gross Profit	₪0
Other Expenses	₪0
Earnings	₪0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did MPRS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 08:12
End of Day Share Price	2024/12/10 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MediPress Health-Limited Partnership is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

MediPress Health-Limited Partnership TASE:MPRS Stock Report